In a recent publication in Cell,Yang and colleagues propose a novel role for the serotonin transporter(SERT)as an immune checkpoint in CD8+T cells.1 These findings highlight the therapeutic potential of selective sero...In a recent publication in Cell,Yang and colleagues propose a novel role for the serotonin transporter(SERT)as an immune checkpoint in CD8+T cells.1 These findings highlight the therapeutic potential of selective serotonin reuptake inhibitors(SSRIs)as anti-tumor drugs.展开更多
基金supported by the National Heart,Lung,and Blood Institute(Grant R01 HL155979).
文摘In a recent publication in Cell,Yang and colleagues propose a novel role for the serotonin transporter(SERT)as an immune checkpoint in CD8+T cells.1 These findings highlight the therapeutic potential of selective serotonin reuptake inhibitors(SSRIs)as anti-tumor drugs.
